Active Ingredient (In Each Immediate-Release Tablet)
Guaifenesin 200 mg
The following Structured Product Label (SPL) was submitted to the FDA by Remedyrepack Inc. for the product Guaifenesin (NDC 49349-511). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each immediate-release tablet), purpose, uses, ask a doctor before use if you have, stop use and ask a doctor if, if pregnant or breast-feeding,, keep out of reach of children., directions, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Guaifenesin 200 mg
Expectorant
helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive
cough lasts more than 7 days, comes back, or occurs with fever, rash, or persistent headache. These could be signs of a serious illness.
ask a health professional before use.
In case of overdose, get medical help or contact a Poison Control Center right away.
| adults and children 12 years
of age and over | 1 to 2 tablets every
4 hours |
| children 6 to under 12 years
of age | ½ to 1 tablet every
|
| children under 6 years of age | consult a physician |
FD&C red #40 aluminum lake, magnesium stearate, maltodextrin, microcrystalline cellulose, povidone, silica gel, sodium starch glycolate, stearic acid
(800) 616-2471
DRUG: Guaifenesin
GENERIC: Guaifenesin
DOSAGE: TABLET
ADMINSTRATION: ORAL
NDC: 49349-511-02
COLOR: pink
SHAPE: ROUND
SCORE: No score
SIZE: 10 mm
IMPRINT: 44;588
PACKAGING: 30 in 1 BLISTER PACK
ACTIVE INGREDIENT(S):
INACTIVE INGREDIENT(S):
* Please review the disclaimer below.